menu search

Investors add foreign equities in august: statscan

The national statistical agency reported that Canadian investors added $14.9 billion worth of foreign securities to their portfolios in August, led by...

October 17, 2023, 8:44 pm

tscan therapeutics: that recent amgen deal is the only point of interest

tscan Therapeutics is developing TCR T-cell therapies for cancer using a transposon-based T cell engine...

October 14, 2023, 3:32 am

tscan therapeutics, inc. (tcrx) upgraded to strong buy: here's why

tscan Therapeutics, Inc. (TCRX) might move higher on growing optimism about its earnings prospects, whi...

October 12, 2023, 1:32 pm

tscan therapeutics, inc. (tcrx) upgraded to buy: here's what you should know

tscan Therapeutics, Inc. (TCRX) might move higher on growing optimism about its earnings prospects, whi...

August 16, 2023, 1:14 pm

tscan therapeutics, inc. (tcrx) reports q2 loss, misses revenue estimates

tscan Therapeutics, Inc. (TCRX) came out with a quarterly loss of $0.51 per share versus the Zacks Cons...

August 10, 2023, 10:01 am

Neogen (neog) introduces improved genomic test for cats

Neogen's (NEOG) My Catscan 2.0 offers insightful genetic information that enables preventive cat care b...

June 15, 2023, 11:02 am

tscan therapeutics announces pricing of $140 million public offering

WALTHAM, Mass., May 26, 2023 (GLOBE NEWSWIRE) — tscan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-s...

May 26, 2023, 4:37 am

tscan therapeutics presents preliminary phase 1 clinical results on tsc-100 and tsc-101 at the american society of gene & cell therapy 26th annual meeting

Poster highlights Phase 1 results following treatment with TSC-100 and TSC-101 after hematopoietic cell transplantation...

May 17, 2023, 7:00 am

tscan therapeutics, inc. (tcrx) reports q1 loss, tops revenue estimates

tscan Therapeutics, Inc. (TCRX) came out with a quarterly loss of $0.93 per share versus the Zacks Cons...

May 10, 2023, 9:55 am

tscan therapeutics stock soars after amgen collaboration on crohn's disease treatment that could bring in more than $500 million

Shares of tscan Therapeutics Inc. TCRX powered up 43.1% in premarket trading Tuesday, after the biophar...

May 9, 2023, 9:15 am

tscan therapeutics announces upcoming trial in progress poster presentation at the american society of gene and cell therapy 26th annual meeting

Company to host a virtual event to discuss highlights from its Phase 1 umbrella trial of TSC-100 and TSC-101 on Wednesday, May 17, 2023, at 5:30 p.m. ...

May 2, 2023, 8:42 pm

Investors dump equities, buy bonds: statscan

Foreign investors piled into Canadian bonds in February while dumping equities, according to new data from Statistics Canada. The national statistical...

April 17, 2023, 7:44 pm

Fda gives nod to tscan therapeutics' early-stage trial of tsc-100 in hematologic malignancies

The FDA has signed off tscan Therapeutics Inc's (NASDAQ: TCRX) investigational new drug (IND) applic...

January 24, 2022, 12:30 pm

Fda gives nod to tscan therapeutics' early-stage trial of tsc-100 in hematologic malignancies

The FDA has signed off tscan Therapeutics Inc's (NASDAQ: TCRX) investigational new drug (IND) applic...

January 24, 2022, 12:30 pm

Fda gives nod to tscan therapeutics' early-stage trial of tsc-100 in hematologic malignancies

The FDA has signed off tscan Therapeutics Inc's (NASDAQ: TCRX) investigational new drug (IND) applic...

January 24, 2022, 12:30 pm


Search within

Pages Search Results: